These studies concluded that genes belonging to the interferon family, the TNF, and cytokines have the potential to be therapeutic targets for breast cancer since they are active before tumor formation in the defense of the body under poor conditions after radiation or estrogen effects. This evidence concerns the gene TNF and neoplasm.